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osting by EAbstract Aim: The aim of the present study was to investigate the immunomodulatory action of
methanolic extract of Aegle marmelos fruit (FEAM) in experimental model of immunity.
Methods: Cellular immunity was carried out by neutrophil adhesion test and carbon clearance
assay, whereas, humoral immunity was analyzed by mice lethality test and indirect haemagglutina-
tion assay. FEAM dose was selected by Stair case method (up and down) and administered at 100
and 500 mg/kg orally. The Ocimum sanctum (OSE, 100 mg/kg, p.o) was used as standard.
Results: FEAM at 100 and 500 mg/kg produced signiﬁcant increases in adhesion of neutrophils
and an increase in phagocytic index in carbon clearance assay. Both high and low doses of FEAM
signiﬁcantly prevented the mortality induced by bovine Pasteurella multocida in mice. Treatment of
animals with FEAM and OSE signiﬁcantly increased the circulating antibody titre in indirect haem-
agglunation test. Among the different doses, low one was more effective in cellular immunity mod-
els than the high. However, all the doses exhibited similar protection in humoral immunity
procedures.
Conclusion: From the above ﬁndings, it is concluded that FEAM possesses potential for augment-
ing immune activity by cellular and humoral mediated mechanisms more at low dose (100 mg/kg)
than high dose (500 mg/kg).
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lsevier1. Introduction
A global reliance on alternative system of medicine for chronic
and acute ailments resulted in an intense area of research and
discovery of a number of herbs with potential to curb diseases.
Among them, ample number of herbs has been exploited for
modulation of immune system from Ayurvedic formulation
either alone or in combinations.
Traditionally, various parts of the plant, Aegle marmelos
Corr. (Rutaceae), used for the treatment of a variety of disor-
ders (Nadkarni, 1986). The plant is reported to have multiple
162 P. Patel, S.M.B. Asdaqtherapeutic properties such as anti-inﬂammatory, antipyretic
and analgesic (Arul et al., 2005; Shankarananth et al., 2007),
anti diabetic (Kamalakkannan et al., 2003; Arumugam et al.,
2008; Kesari et al., 2006), anti diarrheal (Shoba and Thomas,
2001), anti hyperlipidemic (Vijaya et al., 2009), antifungal
(Rana et al., 1997), antimicrobial, antibacterial and anti para-
sitic (Ulahannan et al., 2008), anti cancer (Gangadevi and
Muthumary, 2008), anti malaria (Elango et al., 2009), hepato-
proctective (Singh and Rao, 2008) and cardioprotective (Vimal
and Devaki, 2004) potentials.
Environmental pollutants and dietary habits cause distur-
bances in immune activities and diet containing micronutrients
and antioxidants are known to prevent these alterations (Bafna
and Mishra, 2010). The use of herbs as immunomodulators in
the indigenous system of medicines, indeed, can modulate the
body’s defence mechanism. The following active constituents
of plant derivatives such as polysaccharides, lectins, peptides,
ﬂavonoids and tannins have been reported to modulate the
immune system in different experimental models (Shivaprasad
et al., 2006). The fruit of Aegle marmelos is reported to contain
many functional and bioactive compounds such as carote-
noids, phenolics, alkaloids, coumarins, ﬂavonoids, terpenoids,
and other antioxidants. In addition, it also has many vitamins
and minerals including vitamin C, vitamin A, thiamine, riboﬂa-
vin, niacin, calcium, and phosphorus (Das and Das, 1995).
Therefore, the chemical proﬁle indicatesAeglemarmelos as good
sources of immunomodulatory agents. Further, the fruit of the
plant has been used for many disorders such as chronic diar-
rhoea & dysentery and act as a tonic for the heart and brain. It
is widely used as indigenous traditional medicine for variety of
stress disorders including immunodeﬁciencies (Das and Das,
1995). However, till date no scientiﬁc evaluations are conducted
for conﬁrming its role as immunostimulant. Thus, this studywas
designed to study the immunomodulatory activity of extract of
Aegle marmelos fruit extract in different experimental models
of cellular and humoral immunity in animals.
2. Materials and methods
2.1. Experimental animals
Laboratory bred Wistar albino rats (180–200 g) and albino
mice (20–25 g) of either sex were housed at 25± 5 C in a
well-ventilated animal house under 12/12 h light/dark cycle.
The mice were procured from Drug Testing Laboratory, Ban-
galore. The animals had free access to standard food pellets
(Amrut Laboratory Animal feed, Maharashtra, India) con-
taining (% w/w) protein 22.10, oil 4.13, ﬁbre 3.15, ash 5.15,
sand (silica) 1.12, and water ad libitum. Bedding material was
removed and replaced with fresh paddy husk as often as nec-
essary to keep the animals clean and dry. The animals were
maintained under standard conditions in an animal house ap-
proved by Committee for the purpose of control and supervi-
sion on experiments on animals (CPCSEA). The experimental
protocol was approved by Institutional ethical committee
(KCP/IAEC-24/2008-09). The animals were subjected for
quarantine (10 days) prior to experimentation
2.2. Procurement of plant material and extraction
Aegle marmelos fruits were purchased from S.K.R. Market
Bangalore (India). The plant was identiﬁed and authenticatedby Regional Research Institute (Bangalore, India) (RRCBI-
Mus/02) The fruits were given to Phytotech Extracts Pvt.
Ltd. (Bangalore, India) to get methanol fruit extract of Aegle
marmelos (FEAM). The ethanolic extract of Ocimum sanctum
leaves (Natural remedies, Bangalore, India) was used as stan-
dard immunomodulatory agent (Mediratta et al., 2002).
2.3. Chemicals and their sources
Leishmann’s stain and gluteraldehyde were purchased from
Merck (Mumbai, India). Indian ink from HIMEDIA (Mum-
bai, India). WBC diluting ﬂuid and EDTA from Nice Chemi-
cals (Cochin, India). Pasteurella multocida of bovine origin and
its vaccine were (Institute of Animal Health and Veterinary
Biologicals, Bangalore, India). Nylon ﬁbers (Local market,
Bangalore, India).
2.4. Antigen preparation
Fresh sheep blood was collected from the local slaughterhouse.
Sheep red blood cells (SRBCs) were washed three times in
large volumes of pyrogen free 0.9% normal saline and adjusted
to a concentration of 0.5 · 109 cells/ml for immunization and
challenge (Thomas et al., 2007).
2.5. Preliminary phytochemical screening of extract
Preliminary phytochemical analysis was carried out to check
and identify the active constituents of the methanolic extract
of Aegle marmelos fruit such as alkaloids, carbohydrates, ﬂavo-
noids, terpenes and steroids, saponins and tannins by using test
methods of Draggendorff’s and Mayer’s test, Molisch’s and
Fehling’s test, lead acetate and magnesium ribbon test, Lieber-
mann–Burchard test, foam formation test, ferric chloride test
and gelatin test, respectively (Trease and Evans, 1983).
2.6. Acute toxicity studies (Ghosh, 1984)
The acute toxicity study was carried out to select the dose, by
using up and down or stair case method. Twomice were selected
with a dose of 50 mg/kg orally and examined for a period of 24 h
for mortality. The subsequent doses are then increased by 1.5
factors to attainmaximumnon-lethal andminimum lethal dose.
The extract was found to be safe at the dose of 5 g/kg p.o.
According to ofﬁce of pollution prevention and toxics (OPPT)
guidelines (http://www.epa.gov/oppts/home/guideline.htm)
(Kubavat and Asdaq, 2009), 1/10th and 1/50th of the maximum
safe dose (5 g/kg) corresponding to 500 mg/kg and 100 mg/kg
were selected as high and low doses, respectively.
2.6.1. Experimental protocol
The drug solutions were prepared in distilled water for oral
administration. Immunomodulatory activity was checked both
at cellular and humoral levels. Cellular immunity was evalu-
ated by neutrophil adhesion test and carbon clearance assay,
whereas, humoral immunity was analyzed by mice lethality test
and indirect haemagglutination assay. All the experimental
models had four common groups consisting of six animals
each. Group I, was served as control and received (vehicle
1 ml/100 g, p.o), group II, received the ethanolic extract of
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et al., 2001, whereas groups III and IV were administered low
(100 mg/kg, oral) and high dose (500 mg/kg, oral) of FEAM,
respectively. However, in mice lethality test, an additional neg-
ative control group was also present.
2.6.2. Neutrophil adhesion test (Fulzele et al., 2003; Shinde
et al., 1999)
The rats were pre-treated orally with vehicle or extracts for
14 days. At the end of treatment day 14, blood samples were
collected from the retro-orbital plexus into heparinized vials
and analyzed for differential leukocyte count (DLC). After
the initial counts, blood samples were incubated with 80 mg
nylon ﬁbres/ml for 15 min at 37 C. The incubated blood sam-
ples were again analyzed for TLC and DLC, respectively to
give neutrophil index of blood samples. The percent neutrophil
adhesion was calculated as follows:
Neutrophil adhesion ð%Þ ¼ NIuNIt 100
NIu
ð1Þ
where NIu is the neutrophil index of untreated blood samples
and NIt is the neutrophil index of treated blood samples.
2.6.3. Carbon clearance test (Jayathirtha and Mishra, 2004;
Gokhale et al., 2003)
Swiss albino mice were administered FEAM, vehicle and OSE
treatment orally for 10 days in their respective groups. Forty-
eight hours after the last dose of the drug, animals of all the
groups received intravenous injection of (0.3 ml per 30 g) In-
dian ink (colloidal carbon) via the tail vein. Blood samples
were withdrawn from each animal by retro-orbital plexus at
an interval of 0 and 15 min after the ink injection. A 50-ll
blood sample was mixed with 4 ml of 0.1% sodium carbonate
solution and the absorbance of this solution was determined at
660 nm. The phagocytic index K was calculated using the fol-
lowing formula:
K ¼ ðLogeOD1 LogeOD2Þ
15
ð2Þ
where OD1 and OD2 are the optical densities at 0 and 15 min,
respectively.
2.6.4. Mice lethality test (Ramanatha et al., 1995)
Swiss albino mice were pretreated with FEAM and OSE orally
for 21 days in their respective groups. On the 7th and 17th day
of the treatment, the animals were immunized with haemor-
rhagic septicaemic vaccine (HS vaccine) through subcutaneousTable 1 Effect of FEAM and OSE on neutrophil adhesion test.
Treatment TLC (103/mm3) (A) Neutrophil% (B)
UB NFTB UB NFT
Control 6.6 ± 0.16 6.5 ± 0.16 24.3 ± 0.80 23.5
OSE 100 mg/kg 7.6 ± 0.18 6.8 ± 0.15 27.6 ± 1.08 19.6
FEAM 100 mg/kg 7.7 ± 0.12 6.8 ± 0.13 28.0 ± 1.33 17.6
FEAM 500 mg/kg 7.3 ± 0.86 6.9 ± 0.49 25.5 ± 1.23 18.6
All values are expressed as mean ± SEM of six observations.
UB, untreated blood; NFTB, nylon ﬁber treated blood; OSE, Ocimum
control; Group II-OSE treated; Group III-FEAM 100 mg/kg and Group
*** P< 0.001 when compared to control.route. On the 21st day, the animals were challenged subcutane-
ously with 0.2 ml of lethal dose (25 · LD50) of Pasteurella
multocida (bovine origin) containing 107 cells per ml. The ani-
mals were observed for a period of 72 h and the mortality per-
centage was determined.
2.6.5. Indirect haemagglutination test (Fulzele et al., 2003)
Rats of various groups were pretreated with the drugs for
14 days and all rats of entire groups were immunized with
0.5 · 109 sheep red blood cells (SRBCs) intraperitoneally.
The day of immunization was referred to as day 0. The drug
treatment was continued for 14 more days and blood samples
were collected from each rat at the end of the drug treatment
and the titre value was determined by titrating serum dilutions
(50–100 ll) with SRBC (0.025 · 109 cells) in microtitre plates.
The plates were incubated at room temperature for 2 h and
examined visually for agglutination. The minimum volume
of serum showing heamagglutination was expressed as hea-
magglutination (HA) titre.
2.6.6. Statistical analysis
The statistical signiﬁcance was assessed using one-way analysis
of variance (ANOVA) followed by Bonferroni’s comparison
test. The values were expressed as mean ± SEM and
P< 0.05 was considered signiﬁcant.
3. Results
3.1. Neutrophil adhesion test
Incubation of blood with nylon ﬁbres (NF) produced a de-
crease in the neutrophil counts due to adhesion of neutrophils
to the ﬁbres. Both doses of FEAM and OSE showed signiﬁcant
increase in the neutrophil adhesion when compared to control.
The low dose of FEAM was found to be more effective than
high dose of FEAM. There was also rise in neutrophil count
in untreated blood of all treatment groups (Table 1).
3.2. Carbon clearance test
Both doses of Aegle marmelos extract and OSE showed signif-
icant increase in the phagocytic index when compared to con-
trol indicating that there was increase in the clearance of
colloidal carbon from the blood after administration of these
drugs. However, the clearance was best with low dose of
FEAM and OSE (Table 2).Neutrophil index (A · B) Neutrophil adhesion (%)
B UB NFTB
± 0.8 160.58 ± 5.4 153.5 ± 4.5 4.4 ± 0.6
± 0.4 209.23 ± 6.4 135.0 ± 4.2 35.4 ± 0.6***
± 1.0 220.13 ± 4.7 121.3 ± 8.5 45.1 ± 1.2***
± 1.2 186.88 ± 8.8 129.9 ± 9.1 30.7 ± 2.0***
sanctum extract; FEAM, fruit extract of Aegle marmelos. Group I-
IV-FEAM 500 mg/kg.
Table 2 Effect FEAM and OSE on phagocytic index and HA titre.
Treatment Phagocytic index in carbon clearance assay Haemagglutination (HA) titre (ll)
CONTROL 0.0175 ± 0.0018 0.0875 ± 0.2562
OSE (100 mg/kg, p.o) 0.0483 ± 0.002*** 0.0019 ± 0.0003***
FEAM (100 mg/kg, p.o) 0.0423 ± 0.0027*** 0.0019 ± 0.0003***
FEAM (500 mg/kg, p.o) 0.0416 ± 0.0016*** 0.0044 ± 0.0008***
All values are expressed as mean ± SEM of six observations.
OSE, Ocimum sanctum extract; FEAM, fruit extract of Aegle marmelos. Group I-control; Group II-OSE treated; Group III-FEAM 100 mg/kg
and Group IV-FEAM 500 mg/kg.
*** P< 0.001 when compared to control.
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Mortality was found to be 100% within 72 h in control group
upon administration of Pasteurella multocida. There was
83.33% mortality in vaccinated group without any prior treat-
ment of drug. The low and high doses of FEAM as well as
OSE reduced the mortality percentage to 66.66% (Table 3).
3.4. Indirect haemagglutination test
The haemmagglutinating antibody (HA) titre value was signif-
icantly increased in animals that received vaccination along
with low or high dose of FEAM or OSE compared to animals
that received vaccination alone (Table 2).
4. Discussion
In this study we found that methanolic extract of Aegle marme-
los (FEAM) posseses immunomodulatory activity in experi-
mental models of cellular and humoral immunity. The
extract was found to be most effective at low dose (100 mg/
kg, p.o), whereas, high dose (500 mg/kg, p.o) of FEAM was
moderately effective in modulating immune system. The study
was carried out using four different methods, each of which
provides information about effect on different components
of the immune system. The variety of plant products can mod-
ulate immune reaction either by stimulation or suppression
and may assist as a supportive therapy along with conven-
tional drugs in immune compromised patients (Wagner, 1984).
The neutrophil adhesion to nylon ﬁbres describes the mar-
gination of polymorphonuclear lymphocyte in the blood ves-
sels and the number of macrophages reaching the site of
inﬂammation (Shinde et al., 1999). Both low and high doses
of FEAM (100 and 500 mg/kg, p.o) showed a substantial riseTable 3 Effect FEAM and OSE on mice lethality test.
Treatment dose Mortality ﬁrst day
No drug, no vaccination 2
No drug, vaccination 1
OSE (100 mg/kg, p.o) + vaccination –
FEAM (100 mg/kg, p.o) + vaccination –
FEAM (500 mg/kg, p.o) + vaccination –
OSE, Ocimum sanctum extract; FEAM, fruit extract of Aegle marmelos
without treatment; Group III-OSE treated with vaccination; Group IV-F
with vaccination.in the neutrophil adhesion to nylon ﬁbres. This might be due
to the upregulation of the b2 integrins, present on the surface
of the neutrophils through which they adhere ﬁrmly to the ny-
lon ﬁbres (Srikumar et al., 2005). Hence, it was inferred that
FEAM causes stimulation of neutrophils towards the site of
inﬂammation.
The carbon clearance test was done to evaluate the effect of
drugs on the reticulo endothelial system. The reticuloendothe-
lial system (RES) is a diffuse system consisting of phagocytic
cells. Cells of the RES play a vital role in the clearance of par-
ticles from the bloodstream. When colloidal carbon particles in
the form of ink are injected directly into the systemic circula-
tion, the rate of clearance of carbon from the blood by macro-
phage is governed by an exponential equation (Gokhale et al.,
2003). Since both doses of FEAM as well as OSE showed
remarkable augmentation in the phagocytic index, it is specu-
lated that it might be due to increase in the activity of the retic-
uloendothelial system by prior treatment of animals with
FEAM and OSE.
The mouse lethality test is one of the commonly employed
tests to assess serological responses in animals immunized with
vaccines. Pasteurella multocida is pathogenic to mice (Sabri
et al., 2001). The mouse lethality test involves injecting mice
with the vaccine before administration of the bacterial culture
and determining the mortality percentage (Finco Kent et al.,
2001). The survival of animals is dependent on the ability of
drug to produce adequate antibodies that can counter the
pathogen. Both low and high doses of FEAM as well as
OSE prevented the death of 33.33% of animals at the end of
72 h.
The indirect haem agglutination test was performed to con-
ﬁrm the effect of Aegle marmelos extract on the humoral im-
mune system. It is composed of interacting B cell with
antigens and subsequently proliferating and differentiating
into antibody producing cells. Antibody works by binding withSecond day Third day Mortality percentage
4 – 100
3 1 83.33
1 3 66.66
2 2 66.66
3 1 66.66
. Group I-normal control without vaccination; Group II-vaccinated
EAM 100 mg/kg with vaccination and Group V-FEAM 500 mg/kg
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cross linking to form latex that is more readily ingested by
phagocytic cells (Fulzele et al., 2003). The results showed that
levels of circulating antibodies are increased if the test animals
are pretreated with Aegle marmelos extract or OSE.
In conclusion, both low dose (100 mg/kg, p.o) as well as
high dose (500 mg/kg, p.o) of Aegle marmelos stimulates im-
mune system by acting through cellular and humoral immunity
in experimental models of immunity in animals. However, low
dose was found to be most effective than the high dose. How-
ever, further studies should be carried out to elucidate the rea-
son behind low efﬁcacy of high dose than the low dose of Aegle
marmelos.Acknowledgement
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